1. Home
  2. BCML vs ENTA Comparison

BCML vs ENTA Comparison

Compare BCML & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayCom Corp

BCML

BayCom Corp

HOLD

Current Price

$32.06

Market Cap

338.6M

Sector

Finance

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.73

Market Cap

382.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCML
ENTA
Founded
2004
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
338.6M
382.7M
IPO Year
2018
2012

Fundamental Metrics

Financial Performance
Metric
BCML
ENTA
Price
$32.06
$13.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$34.00
$20.40
AVG Volume (30 Days)
77.6K
197.0K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
4.09%
N/A
EPS Growth
3.81
29.93
EPS
0.75
N/A
Revenue
N/A
$102,814,000.00
Revenue This Year
$13.71
$7.76
Revenue Next Year
$5.25
N/A
P/E Ratio
$43.12
N/A
Revenue Growth
N/A
16.48
52 Week Low
$26.31
$6.44
52 Week High
$33.15
$17.15

Technical Indicators

Market Signals
Indicator
BCML
ENTA
Relative Strength Index (RSI) 59.07 58.75
Support Level $27.59 $13.19
Resistance Level $32.86 $13.97
Average True Range (ATR) 0.74 0.83
MACD -0.02 0.31
Stochastic Oscillator 58.47 73.92

Price Performance

Historical Comparison
BCML
ENTA

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: